X
Email:
sales@ruixibiotech.com

CT-1812 CAS:1802632-22-9

CT-1812

Catalog # Pkg Size Price(USD) Quantity Buy this product
R-C-2100 50mg 925.00
- +
+ Add to cart
R-C-2100 100mg 1250.00
- +
+ Add to cart
R-C-2100 200mg 1750.00
- +
+ Add to cart

Product description

CT-1812 is a first-in-class,orally available sigma-2/PGRMC1 antagonist(alpha beta oligomer receptor antagonist),is being developed by Cognition.sCT-1812 is a novel therapeutic candidate for Alzheimer is disease.


Appearance N/A
Molecular Weight N/A
purity >95%
PDI by GPC <1.5
Solubility N/A
Storage -20℃, protected from light and moisture
Transportation 4-25℃ temperature for up to 3 weeks
Stability 2 years
Document

Related Product